Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: Systematic reviews of clinical effectiveness and cost-effectiveness

Health Technology Assessment

Volumn 19, Issue 86, 2015, Pages 1-95

  Pickett, Karen ^a   Loveman, Emma ^a   Kalita, Neelam ^a   Frampton, Geoff K ^a   Jones, Jeremy ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; NON PRESCRIPTION DRUG;

ACNE; ARTICLE; ATOPIC DERMATITIS; CHRONIC INFLAMMATION; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DERMATITIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC EVALUATION; ECZEMA; FOLLOW UP; HUMAN; METHODOLOGY; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PSORIASIS; QUALITY CONTROL; QUALITY OF LIFE; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHILD; CHRONIC DISEASE; FEMALE; INFLAMMATION; MALE; PROCEDURES; SKIN DISEASES; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFLAMMATION; MALE; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; SKIN DISEASES; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 84945315384     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19860     Document Type: Article

References (137)

1. Schofield J, Grindlay D, and Williams H. Skin Conditions in the UK: A Health Care Needs Assessment. Nottingham: Centre of Evidence Based Dermatology, University of Nottingham; 2009.
2. Ersser SJ, Latter S, Sibley A, Satherley PA, Welbourne S. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2007;3:CD0040S4. http://dx.doi.org/10.1002/14651858.CD004054.pub2
3. British Association of Dermatologists. Eczema. URL: www.bad.org.uk/for-the-public/patientinformation-leaflets/atopic-eczema/?showmore=1&returnlink=http%3a%2f%2fwww.bad.org.uk %2ffor-the-public%2fpatient-information-leaflets#.Vh3uPf-FO70 (accessed 7 June 2013).
4. Burr ML, Dunstan FDJ, Hand S, Ingram JR, Jones KP. The natural history of eczema from birth to adult life: a cohort study. Br J Dermatol 2013;168:1339-42. http://dx.doi.org/10.1111/bjd.12216
5. National Collaborating Centre for Women's and Children's Health. Atopic Eczema in Children. Management of Atopic Eczema in Children from Birth up to the Age of 12 Years. NICE Clinical Guideline. London: Royal College of Obstetricians and Gynaecologists; 2007.
6. British Association of Dermatologists. Psoriasis-An Overview. URL: www.bad.org.uk/for-thepublic/ patient-information-leaflets/psoriasis-an-overview/?showmore=1&returnlink=http%3a% 2f%2fwww.bad.org.uk%2ffor-the-public%2fpatient-information-leaflets#.Vh3uwf-FO70 (accessed 7 June 2013).
7. National Institute for Health and Clinical Excellence. Psoriasis. The Assessment and Management of Psoriasis. NICE Clinical Guideline 153. London: NICE; 2012.
8. Nestle FO, Kaplan DH, Barker J. Mechanisms of Disease: Psoriasis. N Engl J Med 2009;361:496-509. http://dx.doi.org/10.1056/NEJMra0804595
9. Purdy S, de Berker D. Clinical review: Acne. BMJ 2006;333:949-53. http://dx.doi.org/10.1136/ bmj.38987.606701.80
10. National Institute for Health and Care Excellence. NHS Choices: Acne. 2014. URL: www.nhs.uk/ conditions/acne/pages/introduction.aspx (accessed 18 February 2014).
11. Schuttelaar MLA, Vermeulen KM, Drukker N, Coenraads PJ. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol 2010;162:162-70. http://dx.doi.org/10.1111/j.1365-2133.2009.09502.x
12. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994;30:35-9. http://dx.doi.org/10.1016/S0190-9622 (94)70004-4
13. Emerson RM, William HC A, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol 1998;139:73-6. http://dx.doi.org/10.1046/ j.1365-2133.1998.02316.x
14. Kurukulaaratchy R, Fenn M, Matthews S, Hasan Arshad S. The prevalence, characteristics of and early life risk factors for eczema in 10-year-old children. Pediatric Allergy Immunol 2003;14:178-83. http://dx.doi.org/10.1034/j.1399-3038.2003.00036.x
15. Wadonda-Kabondo N, Sterne JA, Golding J, Kennedy CT, Archer CB, Dunnill MG, et al. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 2003;149:1023-8. http://dx.doi.org/10.1111/j.1365-2133.2003.05605.x
16. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLOS ONE 2012;7:e39803. http://dx.doi.org/ 10.1371/journal.pone.0039803
17. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013;133:377-85. http://dx.doi.org/ 10.1038/jid.2012.339
18. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41. http://dx.doi.org/10.1001/archderm.141.12.1537
19. Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011;163:602-9. http://dx.doi.org/10.1111/j.1365-2133.2010.10134.x
20. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 2013;168:1303-10. http://dx.doi.org/10.1111/bjd.12230
21. Huerta C, Rivero E, Garcia Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007;143:1559-65. http://dx.doi.org/10.1001/archderm.143.12.1559
22. Khalid JM, Globe G, Fox KM, Chau D, Maguire A, Chiou CF. Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol 2013;13:9. http://dx.doi.org/10.1186/1471-5945-13-9
23. Robeva R, Assyov Y, Tomova A, Kumanov P. Acne vulgaris is associated with intensive pubertal development and altitude of residence-a cross-sectional population-based study on 6,200 boys. Eur J Pediatr 2013;172:465-71. http://dx.doi.org/10.1007/s00431-012-1907-1
24. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol 2013;168:474-85. http://dx.doi.org/10.1111/bjd.12149
25. The Dairy Council. Acne: Prevalence, Symptoms and Diagnosis. London: The Dairy Council. URL: www.milk.co.uk/page.aspx?intPageID=171 (accessed 14 June 2013).
26. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the UK. Br J Dermatol 2012;167:598-605. http://dx.doi.org/10.1111/j.1365-2133.2012.11037.x
27. Patient. Hidradenitis Suppurativa. 2014. URL: www.patient.co.uk/doctor/hidradenitis-suppurativapro (accessed 2 July 2014).
28. Oakley A and DermNet NZ. Cutaneous Lupus Erythematosus. 2014. URL: http://dermnetnz.org/ immune/cutaneous-lupus.html (accessed 15 August 2014).
29. Neill SM, Tatnall FM, Cox NH. Guidelines for the managment of lichen sclerosus. Br J Dermatol 2002;147:640-9. http://dx.doi.org/10.1046/j.1365-2133.2002.05012.x
30. British Association of Dermatologists. Seborrhoeic Dermatitis. 2012. URL: www.bad.org.uk/ for-the-public/patient-information-leaflets/seborrhoeic-dermatitis (accessed 15 August 2014).
31. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005;22:192-9. http://dx.doi.org/ 10.1111/j.1525-1470.2005.22303.x
32. Evers AWM, Lu Y, Duller P, Van Der Valk PGM, Kraaimaat FW, van de Kerkhof PCM. Common burden of chronic skin diseases? Contributers to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005;152:1175-281. http://dx.doi.org/10.1111/ j.1365-2133.2005.06565.x
33. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35. http://dx.doi.org/10.1186/1477-7525-4-35
34. Schmid-Ott G, Steen T. Skin disorders and quality of life. International Encyclopedia of Rehabilitation. Buffalo, NY: The State University of New York; 2010.
35. Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contributions of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosomatic Res 2013;50:11-15. http://dx.doi.org/10.1016/S0022-3999(00)00210-5
36. Fordham B, Griffiths CEM, Bundy C. Can stress reduction interventions improve psoriasis? A review. Psychology Health Med 2013;18:501-14.
37. Devrimci-Ozguven H, Kundakci N, Kumbaser H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:267-71. http://dx.doi.org/10.1046/j.1468-3083.2000.00085.x
38. Kohli Kurd S, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010;146:891-5. http://dx.doi.org/10.1001/archdermatol.2010.186
39. Wittkowski A, Richards HL, Griffiths CEM, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosomat Med 2004;57:195-200. http://dx.doi.org/10.1016/S0022-3999(03)00572-5
40. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284-90. http://dx.doi.org/10.1111/ j.1365-2133.2004.05776.x
41. Kierbert G, Sorenson SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002;41:151-8. http://dx.doi.org/10.1046/j.1365-4362.2002.01436.x
42. de Jager MEA, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores. Br J Dermatol 2010;163:1099-101. http://dx.doi.org/10.1111/j.1365-2133.2010.09993.x
43. Sampogna F, Sera F, Abeni D. IDI Multipurpose psoriasis research on vital experiences investigators. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004;122:602-7. http://dx.doi.org/10.1046/ j.0022-202X.2003.09101.x
44. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006;13:347-56. http://dx.doi.org/10.1159/000104863
45. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008;59:1009-16. http://dx.doi.org/10.1016/ j.jaad.2008.08.028
46. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407. http://dx.doi.org/10.1016/ S0895-4356(03)00044-1
47. Bowling A. Measuring Disease. Buckingham: Open University Press; 1995.
48. Fox-Rusby J, Cairns J. Approaches to measuring health and life. In Fox-Rushby J, Cairns J, editors. Economic Evaluation. Maidenhead: Open University Press; 2005.
49. Cardiff University. Dermatology Life Quality Index: Information & Conditions Concerning Use. Cardiff: Section of Dermatology, Department of Dermatology & Wound Healing, School of Medicine, Cardiff University; 2014.
50. Tareen RS, Greydanus DE, Jafferany M, editors. Pediatric Psychodermatology: A Clinical Manual of Child and Adolescent Psychocutaneous Disorders. Berlin: Walter de Gruyter & Co.; 2012. http://dx.doi.org/10.1515/9783110273939
51. Prescribing and Primary Care, Health and Social Care Information Centre. Prescriptions Dispensed in the Community: England 2003-13. URL: www.hscic.gov.uk/catalogue/PUB14414 (accessed 11 June 2014).
52. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002;288:2469-75. http://dx.doi.org/10.1001/jama.288.19.2469
53. Griesbach D, Taylor A. Educational Interventions to Prevent Hepatitis C: A Review of the Literature and Expert Opinion. Glasgow: NHS Scotland; 2009.
54. Scottish Intercollegiate Guidelines Network. Management of Atopic Eczema in Primary Care: A National Clinical Guideline. Edinburgh: SIGN; 2011.
55. De Bes J, Legierse CM, Prinsen CAC, De Korte J. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol 2011;91:12-17. http://dx.doi.org/10.2340/ 00015555-1022
56. National Institute for Health and Care Excellence. Atopic eczema in children: NICE Quality Standard (QS44). London: NICE; 2014.
57. The James Lind Alliance. The James Lind Alliance: Eczema Priority Setting Partnership. Southampton: The James Lind Alliance; 2014.
58. National Clinical Guideline Centre. Psoriasis Assessment and Management of Psoriasis. Clinical Guideline Methods, Evidence and Recommendations. London: Royal College of Physicians; 2012.
59. Lapsley P. The double benefits of educational programmes for patients with eczema. BMJ 2006;332:936. http://dx.doi.org/10.1136/bmj.332.7547.936
60. Hamilton Larsen M, Birger Hagen K, Krogstad A-L, Aas E, Klopstad Wahl A. Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: a systematic review. Patient Educ Counsel 2014;94:158-69. http://dx.doi.org/10.1016/ j.pec.2013.10.005
61. Rasmussen GS, Terkildsen Maindal H, Lomborg K. Self-management in daily life with psoriasis: an integrative review of patient needs for structured education. Nurs Res Prac 2012;2012. http://dx.doi.org/10.1155/2012/890860
62. Feldman S, Behnam SM, Behnam SE, Koo JYM. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 2005;53:S85. http://dx.doi.org/10.1016/ j.jaad.2005.04.033
63. Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviours? Health Serv Res 2007;42:1443-63. http://dx.doi.org/10.1111/ j.1475-6773.2006.00669.x
64. Magnezi R, Glasser S, Shaley H, Sheiber A, Reuveni H. Patient activation, depression and quality of life. Patient Educ Counsel 2014;94:432-7. http://dx.doi.org/10.1016/j.pec.2013.10.015
65. Medical Research Council (MRC). Developing and Evaluating Complex Interventions: New Guidance. London: MRC; 2008.
66. Barbarot S, Bernier C, Deleuran M, De Raeve L, Eichenfield L, El Hachem M, et al. Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol 2013;30:199-206. http://dx.doi.org/10.1111/pde.12045
67. Hong J, Nguyen TV, Prose NS. Compassionate care: enhancing physician-patient communication and education in dermatology: Part II: Patient education. J Am Acad Dermatol 2013;68:364.e1-364.e10. http://dx.doi.org/10.1016/j.jaad.2012.10.060
68. Kreuter MW, Sugg Skinner C. Tailoring: what's in a name? Health Educ Res 2000;15:1-4. http://dx.doi.org/10.1093/her/15.1.1
69. Schulz R, Czaja SJ, McKay JR, Ory MG, Belle SH. Intervention Taxonomy (ITAX): describing essential features of interventions (HMC). Am J Health Behav 2010;34:811-21.
70. Lavda AC, Webb TL, Thompson AR. A meta-analysis of the effectiveness of psychological interventions for adults with skin condirtions. Br J Dermatol 2012;167:970-9. http://dx.doi.org/ 10.1111/j.1365-2133.2012.11183.x
71. Ersser SJ, Cowdell F, Latter S, Gardiner E, Flohr C, Thompson AR, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014;1:CD004034. http://dx.doi.org/10.1002/14651858.cd004054.pub3
72. Jackson K, Ersser SJ, Dennis H, Farasat H, More A. The Eczema Education Programme: intervention development and model feasibility. J Eur Acad Dermatol Venereol 2013;28;949-56. http://dx.doi.org/10.1111/jdv.12221
73. Ersser SJ, Farasat H, Jackson K, Dennis H, Sheppard Z, More A. A service evaluation of the Eczema Education Programme: an analysis of child, parent and service impact outcomes. Br J Dermatol 2013;169;629-36. http://dx.doi.org/10.1111/bjd.12414
74. Santer M, Muller I, Yardley L, Burgess H, Selinger H, Stuart BL, et al. Supporting self-care for families of children with eczema with a web-based intervention plus health care professional support: pilot randomized controlled trial. J Med Internet Res 2014;16:e70. http://dx.doi.org/ 10.2196/jmir.3035
75. van der Meer EW, Boot CR, Jungbauer FH, van der Klink JJ, Rustemeyer T, Coenraads PJ, et al. Hands4U: a multifaceted strategy to implement guideline-based recommendations to prevent hand eczema in health care workers: design of a randomised controlled trial and (cost) effectiveness evaluation. BMC Public Health 2011;11:669. http://dx.doi.org/10.1186/ 1471-2458-11-669
76. Bostoen J, Bracke S, De KS, Lambert J. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. Br J Dermatol 2012;167:1025-31. http://dx.doi.org/10.1111/j.1365-2133.2012.11113.x
77. Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol 2008;27:379-87. http://dx.doi.org/10.1037/0278-6133.27.3.379
78. Wenninger K, Kehrt R, den Uv, Lehmann C, Binder C, Wahn U, et al. Structured parent education in the management of childhood atopic dermatitis: The Berlin model. Patient Educ Counsel 2000;40:253-61. http://dx.doi.org/10.1016/S0738-3991(99)00074-9
79. Bandura A. Self-efficacy: towards a unifying theory of behavioral change. Psycholog Rev 1977;84:191-215. http://dx.doi.org/10.1037/0033-295X.84.2.191
80. Bandura A. Self-Efficacy: the Exercise of Control. New York, NY: W.H. Freeman and Company, 1997.
81. Bewley A, Burrage DM, Ersser SJ, Hansen EM, Ward C. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol 2013;28:763-70. http://dx.doi.org/10.1111/ jdv.12174
82. Lavada AC, Thompson AR. Psychosocial impact of skin conditions: interventions for nurses. Dermatolog Nurs 2010;9:38-41.
83. Higgins J. P. Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011.
84. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275-83. http://dx.doi. org/10.1136/bmj.313.7052.275
85. Balato N, Megna M, Di CL, Balato A, Ayala F. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol 2013;168:201-5. http://dx.doi.org/10.1111/j.1365-2133.2012.11205.x
86. Ersser SJ, Cowdell FC, Nicholls PG, Latter SM, Healy E. A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis. J Eur Acad Dermatol Venereol 2012;26:738-45. http://dx.doi.org/10.1111/j.1468-3083.2011.04158.x
87. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006;332:933-8. http://dx.doi.org/10.1136/ bmj.332.7547.933
88. Matsuoka Y, Yoneda K, Sadahira C, Katsuura J, Moriue T, Kubota Y. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. J Dermatol 2006;33:745-52. http://dx.doi.org/10.1111/j.1346-8138.2006.00174.x
89. van Os-Medendorp H, Ros WJ, Eland-de Kok PC, Kennedy C, Thio BH, van der Schuur-van der Zande A, et al. Effectiveness of the nursing programme 'Coping with itch': a randomized controlled study in adults with chronic pruritic skin disease. Br J Dermatol 2007;156:1235-44. http://dx.doi.org/10.1111/j.1365-2133.2007.07919.x
90. Pagliarello C, Calza A, Armani E, di PC, Tabolli S. Effectiveness of an empowerment-based intervention for psoriasis among patients attending a medical spa. Eur J Dermatol 2011;21:62-6. http://dx.doi.org/10.1684/ejd.2010.1197
91. Jaspers JP, Span L, Molier L, Coenraads PJ. A multimodal education and treatment program for young adults with atopic dermatitis: a randomized controlled trial. Dermatol Psychosom 2000;1:148-53. http://dx.doi.org/10.1159/000057970
92. Lora V, Gisondi P, Calza A, Zanoni M, Girolomoni G. Efficacy of a single educative intervention in patients with chronic plaque psoriasis. Dermatology 2009;219:316-21. http://dx.doi.org/ 10.1159/000250826
93. Staab D, von RU, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002;13:84-90. http://dx.doi.org/10.1034/j.1399-3038.2002.01005.x
94. Lambert J, Bostoen J, Geusens B, Bourgois J, Boone J, De SD, et al. A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results. Arch Dermatolog Res 2011;303:57-63. http://dx.doi.org/10.1007/s00403-010-1082-z
95. Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035. http://dx.doi.org/10.1111/j.1365-2133.2008.08832.x
96. Section of Dermatology, Department of Dermatology and Wound Healing School of Medicine Cardiff University Internet. Dermatology Life Quality Index: Information and Conditions Concerning Use. Cardiff: Cardiff University; 2014.
97. Fisker MH, Agner T, Lindschou J, Bonde JP, Ibler KS, Gluud C, et al. Protocol for a randomised trial on the effect of group education on skin-protective behaviour versus treatment as usual among individuals with newly notified occupational hand eczema-the Prevention of Hand Eczema (PREVEX) Trial. BMC Dermatol 2013;13:16. http://dx.doi.org/10.1186/1471-5945-13-16
98. Prinsen CA, Spuls PI, Sprangers MA, de Rie MA, Legierse CM, de KJ. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial. Trials 2012;13:236. http://dx.doi.org/10.1186/1745-6215-13-236
99. Hartman M, Prins M, Swinkels OQ, Severens JL, De BT, Van Der Wilt GJ, et al. Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment. Br J Dermatol 2002;147:538-44. http://dx.doi.org/ 10.1046/j.1365-2133.2002.04920.x
100. Kernick D, Cox A, Powell R, Reinhold D, Sawkins J, Warin A. A cost consequence study of the impact of a dermatology-trained practice nurse on the quality of life of primary care patients with eczema and psoriasis. Br J Gen Prac 2000;50:555-8.
101. Parsi K, Chambers CJ, Armstrong AW. Cost-effectiveness analysis of a patient-centered care model for management of psoriasis. J Am Acad Dermatol 2012;66:563-70. http://dx.doi.org/ 10.1016/j.jaad.2011.02.022
102. van Gils RF, Bosmans JE, Boot CRL, Rustemeyer T, van MW, Van Der Valk PGM, et al. Economic evaluation of an integrated care programme for patients with hand dermatitis. Contact Dermatitis 2013;69:144-52. http://dx.doi.org/10.1111/cod.12095
103. Bathe A, Matterne U, Dewald M, Grande T, Weisshaar E. Educational multidisciplinary training programme for patients with chronic pruritus. Acta Derma Venereol 2009;89:498-501. http://dx.doi.org/10.2340/00015555-0684
104. Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol 2013;27:734-8. http://dx.doi.org/10.1111/ j.1468-3083.2012.04549.x
105. Healthcare Insurance Board. Evaluation of the Combination Day-and Home Treatment of Psoriasis-Primary Research. Diemen, The Netherlands: Health Care Technology Assessment Program; 2000.
106. The Netherlands Organisation for Health Research and Development. E-health in caring for patients with atopic dermatitis. An Economic Evaluation Comparing Usual Care with Internet-Guided Monitoring and Self-Management Training by a Nurse Practitioner. The Hague, The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); 2000.
107. van Os-Medendorp H, Guikers CL, Eland-de Kok PC, Ros WJ, Bruijnzeel-Koomen CA, Buskens E. Costs and cost-effectiveness of the nursing programme 'Coping with itch' for patients with chronic pruritic skin disease. Br J Dermatol 2008;158:1013-21. http://dx.doi.org/10.1111/ j.1365-2133.2008.08477.x
108. Mason JM, Carr J, Buckley C, Hewitt S, Berry P, Taylor J, et al. Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme. BMC Dermatol 2013;13:7. http://dx.doi.org/ 10.1186/1471-5945-13-7
109. Schuttelaar ML, Vermeulen KM, Coenraads PJ. Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol 2011;165:600-11. http://dx.doi.org/ 10.1111/j.1365-2133.2011.10470.x
110. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford: Oxford University Press; 2005.
111. Glick HA, Oshi JA, Sonnad SS, Olsky D. Economic Evaluation in Clinical Trials (Handbooks for Health Economic Evaluation). Oxford: Oxford University Press; 2007.
112. Kirkwood BR, Sterne JAC. Medical Statistics. Malden, MA, Oxford, Carlton, VIC: Blackwell Science Ltd; 2003.
113. Zorginstituut Nederland. Medicijnkosten. URL: www.medicijnkosten.nl/ (accessed 17 June 2014).
114. Kalita, N. Developing and Applying a Framework for the Economic Evaluation of Home-Based Nurse-Led Health Promotion Programmes for Older People. Masters Dissertation. Sheffield: University of Sheffield; 2011.
115. Tappenden P, Campbell F, Rawdin R, Wong R, Kalita N. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review. Health Technol Assess 2012;16(20). http://dx.doi.org/10.3310/hta16200
116. Augustin M, Langenbruch AK, Herberger K, Baade K, Goepel L, Blome C. Quality of life measurement in chronic wounds and inflammatory skin diseases: definitions, standards and instruments. Wound Med 2014;5:29-38. http://dx.doi.org/10.1016/j.wndm.2014.04.008
117. Markle-Reid M, Browne G, Weir R, Gafni A, Roberts J, Henderson SR. The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature. Med Care Res Rev 2006;63:531-69. http://dx.doi.org/10.1177/1077558706290941
118. Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. Health Technol Assess 2008;12(9). http://dx.doi.org/ 10.3310/hta12090
119. Carey ME, Madalia PK, Daly H, et al. Increasing capacity to deliver diabetes self-management education: results of the DESMOND lay educator non-randomized controlled equivalence trial. Diabetic Med 2014;31:1431-8. http://dx.doi.org/10.1111/dme.12483
120. Centre for Reviews and Dissemination (CRD). Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. 3rd edn. York: York Publishing Services Ltd, CRD; 2009.
121. Larsen MH, Hagen KB, Krogstad AL, Aas E, Wahl AK. Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: a systematic review. Patient Educ Counsel 2014;94:158-69. http://dx.doi.org/10.1016/j.pec.2013.10.005
122. Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001;144:104-10. http://dx.doi.org/10.1046/j.1365-2133.2001.03960.x
123. Lewis V, Finlay A. 10 years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symposium Proc 2004;9:169-80. http://dx.doi.org/10.1111/j.1087-0024.2004.09113.x
124. Nijsten T. Dermatology life quality index: time to move forward. J Invest Dermatol 2012;132:11-13. http://dx.doi.org/10.1038/jid.2011.354
125. Basra MK, Gada V, Ungaro S, Finlay AY, Salek SM. Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. Br J Dermatol 2013;169:760-8. http://dx.doi.org/10.1111/bjd.12563
126. Cardiff University. Children's Dermatology Life Quality Index (CDLQI): Information & Conditions Concerning Use. Cardiff: Section of Dermatology, Department of Dermatology & Wound Healing. School of Medicine, Cardiff University; 2014.
127. Salek MS, Jung S, Brincat-Ruffini LA, MacFarlane L, Lewis-Jones MS, Basra MK, et al. Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012. Br J Dermatol 2013;169:734-59. http://dx.doi.org/10.1111/bjd.12437
128. Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003;148:285-90. http://dx.doi.org/10.1046/j.1365-2133.2003.05157.x
129. Kondo-Endo K, Ohashi Y, Nakagawa H, Katsunuma T, Ohya Y, Kamibeppu K, et al. Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD). Br J Dermatol 2009;161:617-25. http://dx.doi.org/10.1111/ j.1365-2133.2009.09177.x
130. Chren M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707-13. http://dx.doi.org/10.1111/1523-1747.ep12365600
131. Chren MM. The Skindex Instruments to measure the effects of skin disease on quality of life. Dermatol Clin 2012;30:231-6. http://dx.doi.org/10.1016/j.det.2011.11.003
132. Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rhuem Dis 2005;64(Suppl II):ii65-8. http://dx.doi.org/10.1136/ard.2004.031237
133. DermNet NZ. PASI score. 2014. URL: www.dermnetnz.org/scaly/pasi.html (accessed 13 August 2014).
134. Henseler T, Schmitt-Rau K. A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis. Int J Dermatol 2008;47:1019-23. http://dx.doi.org/10.1111/j.1365-4632.2008.03753.x
135. DermNet NZ. SCORAD. 2014. URL: http://dermnetnz.org/dermatitis/scorad.html (accessed 13 August 2014).
136. Oranje AP, Glazenburg EJ, Wolkerstorfer A, Waard-van der Spek FB. Practical issues on intrepretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007;157:645-8. http://dx.doi.org/10.1111/ j.1365-2133.2007.08112.x
137. Schram ME, Spuls Ph I, Leeflang MMG, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012;67:99-106. http://dx.doi.org/10.1111/j.1398-9995.2011.02719.x